PATENT CLAIM ANALYSIS

Application Number: 16295482
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "400000"]

Abstract:
Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.

Claim (Index 3):
The method of  claim 1 , wherein the pH of the formulation is between about 4 and about 5.2.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.28571
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15805934', '15268095', '16053164', '15483691', '14934752']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7832285510984321
- 35 USC 102 Novelty (BERT): 0.5618995909284615
- Combined Prediction Score: 0.7610956550814352
- Mean Citation Score: 406.204134
- Max Citation Score: 429.55508
- Similarity Product: 418.1923076905871

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test